Pegdoxine (Doxorubicin Pegylated Liposomal) Ovarian cancer, Kaposi’s sarcoma, and Multiple myeloma.
Name of medicine:- Pegdoxine
Composition:- Doxorubicin Hydrochloride Pegylated
Indication:- Ovarian Cancer, Kaposi’s Sarcoma, and Multiple Myeloma
Description:- Pegdoxine Injection (20 mg/10 ml) is a cancer-fighting drug that belongs to the group of medicines known as Antineoplastic Agents. It is responsible for slowing or stopping the growth of cancerous cells in the body.
What is Pegdoxine?
Pegdoxine injection is an anticancer drug used to treat various types of cancers including Ovarian Cancer, AIDs related to Kaposi’s Sarcoma, Breast Cancer, and Blood Cancer. It comprises Doxorubicin Hydrochloride Pegylated. It belongs to the class of medicines referred to as Antineoplastic drugs, which are also known as cancer-fighting agents.
Clinical Relevance
The clinical relevance of the drug tells about its importance and indications. Before administering the injection, it is necessary to know its relevance, safety, and efficacy. Pegdoxine injection is often prescribed for the treatment of the following diseases.
Ovarian Cancer:- Pegdoxine injection is used in the treatment of cancer that begins in the ovaries (the female organs that produce eggs). It is an effective anticancer regimen given as an injection.
Kaposi Sarcoma:- Pegdoxine can be used to treat Kaposi Sarcoma, a type of cancer in which small blood vessels grow below the surface of the skin and inside the mouth.
Blood Cancer:- This injection is also used in the treatment of certain types of Leukemia, Lymphoma, and Myeloma including acute myeloblastic leukemia, acute lymphoblastic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma (NHL), and multiple myeloma.
Breast Cancer:- Pegdoxine injection is a useful regimen for the treatment of Metastatic Breast Cancer. It is administered as an injection.
-
Category
No comments found